The impact of antitumor effect severity on the long-term results of treatment of patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses
Open Access
- 3 November 2025
- journal article
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (3) , 50-58
Abstract
Introduction. Squamous cell carcinoma of the nasal cavity and paranasal sinuses is one of the rare malignancies. In about 80 % of cases, this pathology is diagnosed at stage III–Iv, which causes an unfavorable prognosis of the disease.Aim. To evaluate effectiveness of an integrated approach to treatment of stage III–Iv squamous cell carcinoma of the nasal cavity and paranasal sinuses.Materials and methods. The study included 126 patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses who were treated and observed during 2000–2020 at the N. N. Blokhin National medical Research Center for Oncology. Depending on the choice of treatment tactics at the 1st stage, patients were divided into 3 groups. group 1 (n = 55) included patients who underwent conservative treatment (radiation or chemoradiation) therapy in an independent version, group 2 (n = 31) – patients who underwent surgery with adjuvant radiation therapy, group 3 (n = 40) – patients who underwent induction radiation or chemoradiation therapy with subsequent surgery. Results. Overall 5-year survival rates did not differ between the 3 groups (p 0.05). At the same time, 5-year progression-free survival in group 2 (surgery + adjuvant radiation or chemoradiation therapy) was significantly higher (50.5 %) as compared with groups 1 (conservative treatment) (17 %; p = 0.021) and 3 (induction radiation or chemoradiation therapy + surgery) (25.5 %; p = 0.031). The five-year progression-free survival of patients with T3 tumor in group 2 was 59.4 %, which was significantly higher than in groups 1 (17.9 %; p = 0.021) and 3 (27.1 %; p = 0.031). However, there were no between-group differences in progression-free survival in patients with T4 tumor.Conclusion. Local recurrence is the most common cause of disease progression. Surgery with adjuvant radiation therapy, especially in patients with T3 tumor, improves the prognosis of the disease. At the same time, it is advisable to conduct conservative treatment to patients with T4 tumor.Keywords
This publication has 21 references indexed in Scilit:
- Intensity‐modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single instituteHead & Neck, 2021
- Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinomaHead & Neck, 2020
- Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current TreatmentCurrent Treatment Options in Oncology, 2020
- Programmed death ligand‐1 expression as immunotherapeutic target in sinonasal cancerHead & Neck, 2018
- Squamous cell carcinoma of the maxillary sinus: A population‐based analysisThe Laryngoscope, 2015
- Salvage surgery for head and neck squamous cell carcinoma2014
- Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009Cancer, 2013
- Incidence and survival in patients with sinonasal cancer: A historical analysis of population‐based dataHead & Neck, 2011
- Malignant Tumors of the Nose and Paranasal Cavity2009
- Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neckHead & Neck, 2003